Intracellular fat deposition
|
|
|
- Mervyn Boone
- 10 years ago
- Views:
Transcription
1 Who Gets Alcoholic Liver Disease? Chris Day Newcastle University
2 Alcoholic Fatty Liver (Steatosis) Fatty hepatocytes Intracellular fat deposition
3 Alcoholic SteatoHepatitis (ASH) Fat deposits Inflammation Fibrosis with necrosis
4 Cirrhosis Cirrhosis Regenerative nodule Fibrosis Nodules surrounded by fibrosis
5 Normal (0-30%) Fatty Liver (60-100%) Prevalence of disease stages in unselected heavy drinkers WHY?? Steatohepatitis (20-30%) Cirrhosis (<10%)
6 Non-genetic (inherited) factors Dose & pattern of alcohol intake Dietary factors Specific nutrients? General excess (obesity) Smoking Becker 2002, Klatsky 2006 Coffee drinking Gut bacteria (the microbiome )? Klatsky 2006
7 ALD & Dose: population level Cirrhosis death rate correlates with per capita alcohol intake Leon et al Lancet 2006
8 ALD & Dose: individual level % of category >12 Drinks per day Cirrhosis Any liver disease Bellentani et al 1997
9 ALD risk and pattern of intake Risk of ALD increased by: Drinking outside meal-times Risk : 3.4[ ] Bellentani 1997 Drinking beer/spirits rather than wine Risk : 2.5[ ] Becker 2002 Daily versus weekend drinking Risk : 2.5 [ ] Stokkeland 2008
10 Is wine vs beer effect due to confounding lifestyle factors? Johansen, Friis, Skovenborg, Gronbaek BMJ 2006
11 Diet and ALD: the role of obesity % overweight With lesion Without lesion Steatosis Hepatitis Cirrhosis 1604 heavy drinkers Overweight = minimum BMI>25 women, >27 men in previous 10yr In multivariate analysis obesity/glucose best predictors of cirrhosis (Risk > x 2 for obesity) Naveau et al 1997 Raynard et al 2002
12 Rates of liver cirrhosis in 1,230,662 UK women (mean age 56yrs) followed up for mean 6.2 years Liu Br Med J 2010
13 Relative risks of contributions of BMI and alcohol to liver disease mortality (adjusted for all risk factors). 9,559 Scottish men followed up for mean 29 years Hart Br Med J 2010
14 Obesity & ALD:?explanation for association Mechanisms of ALD & obesity related liver disease (NAFLD) very similar: Metabolic overload Oxidative, ER and cytokine mediated stress The microbiome/endotoxinendotoxin Direct fibrogenic (scar producing) effects of obesity High Insulin/glucose Adipokine profile
15 Risk of ALD and coffee drinking Coffee intake Relative Risk of ALD Never/seldom 1.0 <1 0.7 [ ] [ ], 0.8], p< [ ], 0.4], p<0.001 Per cup/day 0.8[ ], 0.9], p<0.001 Adjusted for age, weight, smoking, gender, ethnicity Klatsky 2006
16 Gut bacteria - the microbiome - and ALD susceptibility? Abundant evidence that the gut microbiome may be involved in ALD pathogenesis Purohit 2008 Non-alcoholic steatohepatitis (NASH) as a transmissible disease? What about ALD? Henao-Mejia Nature 2012 Faeces from ALD patients induce ALD in alcohol fed mice Llopis 2013
17 Tilg & Day Nat Clin Practice 2007
18 Gender and ALD Females develop ALD at lower intake Explanation: blood alcohol levels for same dose per body weight Vol distribution Marshall 1983 Estrogen sensitises the liver (Kupffer cells) to bacterial (endo) toxins gut permeability to endotoxin Endotoxin receptors (CD14) & release of inflammatory mediators from liver inflammatory cells (eg. TNFa) Thurman et al 1999
19 Tilg & Day Nat Clin Practice 2007
20 Are genes important? Concordance rates (%) among male twin pairs age Alcoholism and cirrhosis 25%. MZ DZ MZ DZ Ethnic variation in susceptibility Caetano & Clark 1998, Stinson 2001, Klatsky 2006 Alcoholism Cirrhosis Alcoholism Cirrhosis Alcoholism genetic ALD genetic Risk over-and-above the risk of alcoholism Hrubec 1981 Alcoholism genetic ALD risk now shared with alcoholism No longer a significant independent genetic risk for ALD Reed 1996
21 Finding the genes Hypothesis-driven Candidate gene case-control control studies All studies in ALD thus far Almost all underpowered (too small) Hypothesis-free (generating) Whole genome scanning None in ALD as yet (underway) BUT: Clues from studies in NAFLD
22 NIH-PA Author Manuscript NIH-PA NIH-PA Author Manuscript NIH-PA Author Manuscr Romeo et al. USA Study population: (Black n=1032, White n=636, Hispanic n=383) non-synonymous exonic SNPs. Steatosis defined non-invasively by 1 H-MRS. Romeo et al. PNPLA3 (I148M) Carriage of G allele associated with increased steatosis (p=5.9 x )
23 Presence of NASH OR 1.5 ( ) N=591 Fibrosis >F1 OR 1.5 ( )
24 PNPLA3 - Adiponutrin But why the link with NASH & scarring? He et al, 2010 Huang et al, 2010 Huang et al, 2011 Pirazzi et al, 2012 Anstee et al, 2013
25
26
27 Case control studies of PNPLA3 in ALD Study Numbers Ethnicity Associated phenotype Tian, ,221 Mexican- European Risk of ALD and cirrhosis Seth, UK Risk of ALD and cirrhosis Stickel, ,043/376 German Risk of ALD and cirrhosis Trepo, Belgian Risk of ALD and cirrhosis Trepo Belgian and French Risk of HCC Nischalke Germany Risk of HCC
28 TM6SF2 (E167K) Carriage of minor allele associated with increased steatosis (p=5.7 x 10-8 ) Carriage of major allele increased cholesterol and cardiovascular disease See also: Holmen et al, Nature Genetics, 2014
29 Nature Communications, 2014; /ncomms5309. Multivariate analysis (additive model) incorporating Age, Gender, BMI, T2DM and PNPLA3 rs genotype. i.e. OR per copy of the minor allele carried
30 Obesity Alcohol T2DM T-allele Lys167 (E167K) Hepatic VLDL Excretion TG LDL-C Intrahepatic Fatty Acid Flux TM6SF2 rs C-allele Glu167 (E167K) Does TM6SF2 genotype determine the CAUSE of death in NAFLD/ALD? Hepatic VLDL Excretion TG LDL Total Chol IHTG Steatosis? NASH Fibrosis Cardiovascular Disease
31 TM6SF2 gene variant determines risk of liver and heart disease Dongiovanni 2014
32 Conclusions ALD is a typical complex disease with susceptibility likely due to a combination of genetic/environmental factors Several modifiable environmental risk factors such as diet/coffee drinking identified Role of the microbiome as a modifiable and?transmissible risk factor worthy of further study PNPLA3 is the only robust genetic association reported thus far and is also associated with HCC Genetic factors may explain CAUSE of death in heavy drinkers Genome wide scans are awaited with interest
New Approaches to Treating Fatty Liver Disease. Mack C. Mitchell, MD University of Texas Southwestern Medical Center Dallas, Texas
New Approaches to Treating Fatty Liver Disease Mack C. Mitchell, MD University of Texas Southwestern Medical Center Dallas, Texas Disclosures Stockholder: Bristol-Myers Squibb, Medtronic, Novartis, Pfizer
NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center
NASH: It is not JUST a Fatty Liver Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center Stages of Fatty Liver Disorders Fatty Liver 16-35% of Western
Non-alcoholic fatty liver disease: Prognosis and Treatment
Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis
THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points
December 2008 (Vol. 1, Issue 3, pages 36-40) THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES By Sophie Lotersztajn, PhD, Ariane Mallat, MD, PhD Inserm U841, Hôpital Henri Mondor,
SHAHID AZIZ DO, FACOI.
SHAHID AZIZ DO, FACOI. ASSOCIATE CLINICAL PROFESSOR OF GI AND LIVER DISEASE. UT SOUTHWESTERN HEALTH SCIENCE CENTER, DALLAS ADJUNCT CLINICAL ASSISTANT PROFESSOR DEPT OF MEDICINE UNT HEALTH SCIENCE CENTER
Abnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London
Abnormal Liver Function Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Does Liver Disease Matter? Mortality in England & Wales Liver-related
Alcohol and the Liver
The facts about... Alcohol and the Liver Five key things you need to know This is a part of your body that regularly works overtime. The liver is our largest organ and it has 500 different roles. One of
Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
BACKGROUND MEDIA INFORMATION Fast facts about liver disease
BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of
Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613
Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613 1 Definition Hypertension is a chronic medical condition in which the blood pressure in the arteries is elevated. 2 Primary
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
Liver, Gallbladder, Exocrine Pancreas KNH 406
Liver, Gallbladder, Exocrine Pancreas KNH 406 2007 Thomson - Wadsworth LIVER Anatomy - functions With disease blood flow becomes obstructed Bile All bile drains into common hepatic duct Liver Bile complex
Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care
Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care This advice has been developed to help GPs with shared care of patients with Non- Alcohol
Insulin Receptor Substrate 1 (IRS1) Gene Variation Modifies Insulin Resistance Response to Weight-loss Diets in A Two-year Randomized Trial
Nutrition, Physical Activity and Metabolism Conference 2011 Insulin Receptor Substrate 1 (IRS1) Gene Variation Modifies Insulin Resistance Response to Weight-loss Diets in A Two-year Randomized Trial Qibin
Give a NOD to diabetes:
Give a NOD to diabetes: NOD proteins ti link immunity it and metabolism tbli Jonathan Schertzer McMaster University McMaster University Faculty of Health Sciences Department of Biochemistry and Biomedical
THE FAT YOU CAN T SEE
THE FAT YOU CAN T SEE in growing numbers of people, the liver holds a hidden, dangerous store of fat. finding the triggers is step one. written by Sarah C.P. Williams & illustrated by Graham Roumieu a
Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου
ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥΔΩΝ «Η ΔΙΑΤΡΟΦΗ ΣΤΗΝ ΥΓΕΙΑ ΚΑΙ ΣΤΗ ΝΟΣΟ» Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου Γεώργιος Ντάιος Παθολογική Κλινική Πανεπιστημίου Θεσσαλίας Stroke Statistics
Steatosi, infiammazione e fibrosi: meccanismi patogenetici e interazioni
Steatosi, infiammazione e fibrosi: meccanismi patogenetici e interazioni Fabio Marra Dipartimento di Medicina Sperimentale e Clinica University of Florence, Italy [email protected] Female, 72 years
Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease Information for patients and families UHN Read this information to learn: what non-alcoholic fatty liver disease is what causes it how it s treated how to prevent it where
Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.
JSNA Coronary heart disease 1) Key points 2) Introduction 3) National picture 4) Local picture of CHD prevalence 5) Mortality from coronary heart disease in Suffolk County 6) Trends in mortality rates
Alcoholic Liver Disease in Women
Clinical Medicine Alcoholic Liver Disease in Women JMAJ 45(3): 111 117, 2002 Masayoshi YAMAUCHI Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei
MANAGEMENT OF LIVER CIRRHOSIS
MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different
Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO
Diabetes and Obesity in Children Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO Diabetes and Obesity in Children What is Diabetes? How are Diabetes and Obesity
Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
Appendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
ALPHA (TNFa) IN OBESITY
THE ROLE OF TUMOUR NECROSIS FACTOR ALPHA (TNFa) IN OBESITY Alison Mary Morris, B.Sc (Hons) A thesis submitted to Adelaide University for the degree of Doctor of Philosophy Department of Physiology Adelaide
CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE
CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE What is Cholesterol? What s wrong with having high cholesterol? Major risk factor for cardiovascular disease Higher the cholesterol higher the
Introduction. Pathogenesis of type 2 diabetes
Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic
JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President
Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center
ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits
VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the
Nonalcoholic Fatty Liver Disease. Dietary and Lifestyle Guidelines
Nonalcoholic Fatty Liver Disease Dietary and Lifestyle Guidelines Risk factors for NAFLD Typically, but not always seen in patients who are overweight. May have Diabetes and or insulin resistance high
Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke
Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.
Non Alcoholic Steato-Hepatitis (NASH)
Non Alcoholic Steato-Hepatitis (NASH) DISCLAIMER NEITHER THE PUBLISHER NOR THE AUTHORS ASSUME ANY LIABILITY FOR ANY INJURY AND OR DAMAGE TO PERSONS OR PROPERTY ARISING FROM THIS WEBSITE AND ITS CONTENT.
Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait
TWINS AND GENETICS TWINS Heritability: Twin Studies Twin studies are often used to assess genetic effects on variation in a trait Comparing MZ/DZ twins can give evidence for genetic and/or environmental
Cardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
Risk Factors for Alcoholism among Taiwanese Aborigines
Risk Factors for Alcoholism among Taiwanese Aborigines Introduction Like most mental disorders, Alcoholism is a complex disease involving naturenurture interplay (1). The influence from the bio-psycho-social
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
The Polyphenol Study. Effect of Dietary Polyphenols on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome
The Polyphenol Study Effect of Dietary Polyphenols on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome Principal Investigator: Michael Lefevre, PhD What are Polyphenols? * Polyphenols
Diabetes and Obesity. The diabesity epidemic
Diabetes and Obesity Frank B. Diamond, Jr. M.D. Professor of Pediatrics University of South Florida College of Medicine The diabesity epidemic Prevalence of diabetes worldwide was over 135 million people
Boehringer Ingelheim- sponsored Satellite Symposium. HCV Beyond the Liver
Boehringer Ingelheim- sponsored Satellite Symposium HCV Beyond the Liver HCV AS A METABOLIC MODIFIER: STEATOSIS AND INSULIN RESISTANCE Francesco Negro University Hospital of Geneva Switzerland Clinical
NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
Do You Know the Health Risks of Being Overweight?
Do You Know the Health Risks of Being Overweight? U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH WIN Weight-control Information Network What are the risks to my health from
inflammation of the pancreas and damage to the an increased risk of hypertension, stroke and Table 7.1: Classification of alcohol consumption
H E A LT H SURVEY Alcohol Consumption 7 Alcohol Consumption N AT I O N A L Introduction Excessive alcohol consumption is associated with inflammation of the pancreas and damage to the an increased risk
How To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype
Blood clot in atheroma. help make vitamin D and hormones, like oestrogen and testosterone, in your body.
CHOLESTEROL This factsheet explains what cholesterol is and why too much cholesterol in your blood is harmful. It also provides information regarding cholesterol testing and tips to help reduce your blood
Dietary Composition for Weight Loss and Weight Loss Maintenance
Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review D Shyangdan, 1 C Clar, 2 N Ghouri,
Diabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
High Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012
Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department
Why are some drugs only available on prescription? Depressants. Pain killers. Stimulants. Performance enhancers. Hallucinogens
Explain the terms Addiction Tolerance How are drugs classified? Class A = Class C= In tobacco smoke what do the following cause? Explain the effect of a depressant on the synapse CO Withdrawal symptoms
Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus?
Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus? Henry Ginsberg, MD Columbia University College of Physicians and Surgeons Henry Ginsberg: Disclosures Research
Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP
Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP Habit is habit, and not to be flung out of the window by any man, but coaxed down-stairs one step at a time. Samuel Langhorne Clemens
Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases
Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases M. Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine, MUG Co- Investigator: H. Samonigg,
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases
SIXTY-SIXTH WORLD HEALTH ASSEMBLY A66/8 Provisional agenda item 13.1 15 March 2013 Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases
The relationship between socioeconomic status and healthy behaviors: A mediational analysis. Jenn Risch Ashley Papoy.
Running head: SOCIOECONOMIC STATUS AND HEALTHY BEHAVIORS The relationship between socioeconomic status and healthy behaviors: A mediational analysis Jenn Risch Ashley Papoy Hanover College Prior research
ALCO H O L AN D H EALTH THE EFFECTS OF MODERATE, REGULAR ALCOHOL CONSUMPTION
ALCO H O L AN D H EALTH THE EFFECTS OF MODERATE, REGULAR ALCOHOL CONSUMPTION ISBN 2-9807330-6-7 Legal deposit 2005 A l c o h o l a n d H e a l t h THE HEALTH BENEFITS OF MODERATE AND REGULAR ALCOHOL CONSUMPTION
PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto
PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized
Healthy life resources for the cancer community. Tonight: Healthy Eating with Diane B. Wilson, EdD, RD. January 18, 2012
Living Well after Cancer Healthy life resources for the cancer community Tonight: Healthy Eating with Diane B. Wilson, EdD, RD Yoga with Mary Shall, PhD, PT January 18, 2012 Optimizing i i the health
Nutrition for Family Living
Susan Nitzke, Nutrition Specialist; [email protected] Sherry Tanumihardjo, Nutrition Specialist; [email protected] Amy Rettammel, Outreach Specialist; [email protected] Betsy Kelley,
Margarines and Heart Disease. Do they protect?
Margarines and Heart Disease Do they protect? Heart disease Several studies, including our own link margarine consumption with heart disease. Probably related to trans fatty acids elevate LDL cholesterol
Dietary Fiber and Alcohol. Nana Gletsu Miller, PhD Spring 2014
Dietary Fiber and Alcohol Nana Gletsu Miller, PhD Spring 2014 Dietary Fiber It is the complex carbohydrate in plants that can not be broken down by human digestive enzymes Sources Grains Fruits and Vegetables
Using Family History to Improve Your Health Web Quest Abstract
Web Quest Abstract Students explore the Using Family History to Improve Your Health module on the Genetic Science Learning Center website to complete a web quest. Learning Objectives Chronic diseases such
DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE
DIABETES AND INSULIN RESISTANCE KARI KOHRS RD LDN CDE UICMC NUTRITION & WELLNESS CENTER DIABETES PREVALANCE Third leading cause of death-- United States 18 million diagnosed Growing at the rate of 3 new
Social inequalities in all cause and cause specific mortality in a country of the African region
Social inequalities in all cause and cause specific mortality in a country of the African region Silvia STRINGHINI 1, Valentin Rousson 1, Bharathi Viswanathan 2, Jude Gedeon 2, Fred Paccaud 1, Pascal Bovet
Kansas Behavioral Health Risk Bulletin
Kansas Behavioral Health Risk Bulletin Kansas Department of Health and Environment November 7, 1995 Bureau of Chronic Disease and Health Promotion Vol. 1 No. 12 Diabetes Mellitus in Kansas Diabetes mellitus
Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc.
Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc. UIC study finds subjects on Isagenix products lost more body fat, lost more visceral fat, showed greater adherence,
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
Family History and Diabetes. Practical Genomics for the Public Health Professional
Family History and Diabetes Practical Genomics for the Public Health Professional Outline Overview of Type 2 Diabetes/Gestational Diabetes Familial/Genetic Nature of Diabetes Interaction of Genes and Environment
What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic
What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning
Validation and Replication
Validation and Replication Overview Definitions of validation and replication Difficulties and limitations Working examples from our group and others Why? False positive results still occur. even after
Non-alcoholic Fatty Liver Disease (NAFLD): Does Anything Help?
Non-alcoholic Fatty Liver Disease (NAFLD): Does Anything Stephen Caldwell, MD Director of Hepatology University of Virginia Case: 36 yo F, T2 DM, abn liver enzymes, mother died of cryptogenic cirrhosis
Brochure More information from http://www.researchandmarkets.com/reports/3503782/
Brochure More information from http://www.researchandmarkets.com/reports/3503782/ Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in Development, Regulatory Guidelines and
Big Data for Population Health and Personalised Medicine through EMR Linkages
Big Data for Population Health and Personalised Medicine through EMR Linkages Zheng-Ming CHEN Professor of Epidemiology Nuffield Dept. of Population Health, University of Oxford Big Data for Health Policy
Overview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU
Overview and update of modern type 2 Diabetes philosophy and management Dr Steve Stanaway Consultant Endocrinologist BCU Diabetes economics 2009: 2.6M adults with DM in UK (90% type 2) 2025: est. > 4M
Alcohol: The good, the bad and
Alcohol: The good, the bad and the Clare Wilhelm, Ph.D. Portland VA Medical Center Oregon Health & Science University Supported by VA Career Development Grant (BX001294) Overview Alcohol statistics the
Fat and Viral Liver Disease
Fat and Viral Liver Disease Francesco Negro Viropathology Unit University of Geneva Medical Center Geneva, Switzerland Mainz, September 20, 2008 Steatosis and HBV Steatosis in HBV infection: prevalence
